Context:

Robert F. Kennedy Jr. will testify on Capitol Hill for the first time this year to defend a plan by President Trump to slash the Health and Human Services budget, as seven congressional hearings over the next week set up a high-stakes debate on U.S. health policy ahead of the midterms. His testimony follows a tumultuous tenure at HHS marked by mass layoffs, grant terminations, lawsuits and turnover, with the CDC lacking a permanent director and a stalled nomination for surgeon general. Democrats are using the hearings to criticize Kennedy and Trump for rising health costs and policy upheaval. Public trust in Kennedy’s reliability remains low, underscoring a broader struggle over credible health messaging. The events signal a contentious policy battleground that could shape the health landscape through the next electoral cycle.

Dive Deeper:

• Kennedy is scheduled to testify before seven congressional committees or subcommittees over the next week, including two hearings on Thursday, marking his first face‑to‑face with lawmakers since the CDC leadership change last summer.

• Trump’s 2027 budget proposal includes a about 12 percent cut to HHS funding, with the plan to eliminate several NIH institutes or centers entirely, including one focused on alternative medicine, despite Kennedy’s followers typically supporting alternative therapies.

• The department’s upheaval includes mass layoffs, terminations of grants, lawsuits and high turnover, and the CDC still does not have a permanent director, while the Senate has stalled Dr. Casey Means’s nomination as surgeon general.

• Democrats, led by health-policy advocates, argue that the policy shifts are fueling higher health costs and eroding public health infrastructure, prompting calls for Kennedy’s resignation and the release of a critical report on Kennedy and Trump’s health stance.

• Polls cited by the piece show that fewer than 40 percent of Americans consider Kennedy trustworthy, a contrast to higher confidence in Dr. Fauci, reflecting a fragile public trust environment around Kennedy’s health agenda.

• Kennedy has framed his approach around ‘radical transparency’ and ‘gold-standard science,’ even as critics contend the administration’s cuts would aggravate access and affordability issues.

• The hearings are positioned as a prelude to a broader political battle over U.S. health policy ahead of the midterm elections, with implications for funding, oversight, and the direction of federal health programs.